Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Intervention In Kava Labeling Suit Sought By Jarrow Formulas

This article was originally published in The Tan Sheet

Executive Summary

FDA should release an official statement or publish a proposed rule requiring warnings on kava supplements "if available sound science supports such rulemaking," Jarrow Formulas says in an Oct. 4 citizen petition

You may also be interested in...



SupplySide West In Brief

Condition-targeted probiotics: Danisco stresses the condition-specific science behind its probiotics with the launch of HOWARU Restore. According to the firm, a placebo-controlled study of antibiotic users found the bifidobacteria levels in individuals taking Restore returned to baseline "immediately following antibiotic therapy." The number and balance of healthy intestinal microflora were also better maintained in the treatment group. "Many probiotic suppliers employ a one-strain-does-it-all approach to probiotic efficacy," Global Probiotics Business Director Scott Bush said. "Danisco's unique screening strategy utilizing in vitro and in vivo models allows selection of the best strain or blend for each condition," he continued. The antibiotic study is the "first in a line of condition-specific studies by Danisco," according to Bush. The newest probiotic blend under the HOWARU umbrella is recommended for use in supplements and nutritionals and can be stored for up to two years in dry, capsule form, Danisco says...

SupplySide West In Brief

Condition-targeted probiotics: Danisco stresses the condition-specific science behind its probiotics with the launch of HOWARU Restore. According to the firm, a placebo-controlled study of antibiotic users found the bifidobacteria levels in individuals taking Restore returned to baseline "immediately following antibiotic therapy." The number and balance of healthy intestinal microflora were also better maintained in the treatment group. "Many probiotic suppliers employ a one-strain-does-it-all approach to probiotic efficacy," Global Probiotics Business Director Scott Bush said. "Danisco's unique screening strategy utilizing in vitro and in vivo models allows selection of the best strain or blend for each condition," he continued. The antibiotic study is the "first in a line of condition-specific studies by Danisco," according to Bush. The newest probiotic blend under the HOWARU umbrella is recommended for use in supplements and nutritionals and can be stored for up to two years in dry, capsule form, Danisco says...

SupplySide West In Brief

Condition-targeted probiotics: Danisco stresses the condition-specific science behind its probiotics with the launch of HOWARU Restore. According to the firm, a placebo-controlled study of antibiotic users found the bifidobacteria levels in individuals taking Restore returned to baseline "immediately following antibiotic therapy." The number and balance of healthy intestinal microflora were also better maintained in the treatment group. "Many probiotic suppliers employ a one-strain-does-it-all approach to probiotic efficacy," Global Probiotics Business Director Scott Bush said. "Danisco's unique screening strategy utilizing in vitro and in vivo models allows selection of the best strain or blend for each condition," he continued. The antibiotic study is the "first in a line of condition-specific studies by Danisco," according to Bush. The newest probiotic blend under the HOWARU umbrella is recommended for use in supplements and nutritionals and can be stored for up to two years in dry, capsule form, Danisco says...

Related Content

Topics

UsernamePublicRestriction

Register

PS094671

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel